In the final quarter of 2014, Chimerix, a biopharmaceutical company in Durham, lost over $20 million. Yet the company is hiring employees and ramping up spending in the local community. Wall Street can’t get enough of the… Read More »
In recent years, the University of California has benefited from an annual infusion of nearly $100 million. That money didn’t come from state coffers or private donors. It came from royalties and fees generated by the 11,500… Read More »
In the rush to pass inventor killing legislation, only one inventor was allowed to testify in House Judiciary Committee hearings and inventors were silenced altogether by the Senate Judiciary Committee. Almost all of the hearing witnesses were… Read More »
The House Judiciary Committee’s lopsided approval of patent reform legislation last month would not have looked as overwhelming if every member showed up. Six of the seven members of the committee who were absent told The Hill… Read More »
Apple recently released a new app — ResearchKit — that could allow millions of patients to locate and participate in clinical trials through their iPhones. Seattle-based nonprofit Sage Bionetworks helped create the game-changing technology. The crowd-sourced data… Read More »
Congress continues wrestling with legislation intended to stop abusive practices by so-called patent trolls – those financial mischief-makers who abuse loopholes in patent law to get rich at the detriment of scientific progress. It’s critical that Congress… Read More »
If patent reform legislation is going to pass in this Congress, consensus will be needed over any reform of the inter partes review process. Since Kyle Bass and Erich Spangenberg started challenging the validity of a series… Read More »
You can only talk about so many “urgent,” “pressing,” or “huge” problems facing America before the rhetoric starts to wear thin and expose your true values, and that is exactly what is happening to President Obama in… Read More »
One of the more contentious patent reform issues continues to be associated with statutory fee-shifting language that would codify a loser-pays system. In an attempt to win support from Universities, who have come together to oppose patent… Read More »
Researchers in Ann Arbor will soon begin testing a new schizophrenia treatment. That’s great news for the 84,000 Michigan residents who suffer from this disease. By volunteering to receive this new therapy, people with schizophrenia will join… Read More »
